NEXN and cardiac hypertrophy: Loss of CLK4 reduces Nexilin phosphorylation and results in disrupted cytoskeletal anchoring, sarcomeric instability, and cardiac hypertrophy; restoration of the Nexilin phosphorylation has been shown to rescue the phenotype35.